GAO Hospital Drug Price Report Hints At Hefty Reimbursement Cuts In 2006
Executive Summary
Government Accountability Office data on Medicare hospital outpatient drug prices suggest a number of drugs could see significant reimbursement cuts in 2006
You may also be interested in...
Medicare Aranesp Reimbursement Drops “Equitable Adjustment” To Procrit
Medicare will no longer consider Amgen's Aranesp to be "functionally equivalent" to Johnson & Johnson's Procrit when reimbursing hospitals for outpatient use of the biological product
Medicare Aranesp Reimbursement Drops “Equitable Adjustment” To Procrit
Medicare will no longer consider Amgen's Aranesp to be "functionally equivalent" to Johnson & Johnson's Procrit when reimbursing hospitals for outpatient use of the biological product
Hospitals Should Be Reimbursed For Outpatient Rx Handling, MedPAC Says
The Hospital Outpatient Prospective Payment System should include a payment adjustment for pharmaceutical handling costs, the Medicare Payment Advisory Committee recommended during an April 21 meeting in Washington, D.C